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Abstract
The H3K9me3 histone modification is often found at promoter regions, where it functions to repress transcription. However,
we have previously shown that 39 exons of zinc finger genes (ZNFs) are marked by high levels of H3K9me3. We have now
further investigated this unusual location for H3K9me3 in ZNF genes. Neither bioinformatic nor experimental approaches
support the hypothesis that the 39 exons of ZNFs are promoters. We further characterized the histone modifications at the
39 ZNF exons and found that these regions also contain H3K36me3, a mark of transcriptional elongation. A genome-wide
analysis of ChIP-seq data revealed that ZNFs constitute the majority of genes that have high levels of both H3K9me3 and
H3K36me3. These results suggested the possibility that the ZNF genes may be imprinted, with one allele transcribed and
one allele repressed. To test the hypothesis that the contradictory modifications are due to imprinting, we used a SNP
analysis of RNA-seq data to demonstrate that both alleles of certain ZNF genes having H3K9me3 and H3K36me3 are
transcribed. We next analyzed isolated ZNF 39 exons using stably integrated episomes. We found that although the
H3K36me3 mark was lost when the 39 ZNF exon was removed from its natural genomic location, the isolated ZNF 39 exons
retained the H3K9me3 mark. Thus, the H3K9me3 mark at ZNF 39 exons does not impede transcription and it is regulated
independently of the H3K36me3 mark. Finally, we demonstrate a strong relationship between the number of tandemly
repeated domains in the 39 exons and the H3K9me3 mark. We suggest that the H3K9me3 at ZNF 39 exons may function to
protect the genome from inappropriate recombination rather than to regulate transcription.
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Introduction
It is becoming increasingly clear that understanding human
health and disease requires a detailed knowledge of both the
genetic and epigenetic variations in the human population.
Epigenomes are characterized by methylated DNA and certain
modified histones. The patterns of methylated DNA and modified
histones can vary greatly from cell type to cell type and large
changes within a cell type have also been observed when
comparing normal to diseased tissue [1,2,3,4,5,6,7,8]. Ongoing
research is currently investigating how epigenomes differ from
individual to individual when comparing the same cell type
collected from many different people (http://www.roadmapepi
genomics.org/). Six different modified histones have been chosen
as the focus of a large amount of research due to their association
with specific gene structures. For example, H3K9Ac, H3K4me3,
H3K27me3, and H3K9me3 are histone modifications that can be
found at promoter regions, whereas other modified histones are
associated with enhancer regions (e.g H3K4me1) or with
transcribed units (e.g. H3K36me3).
As indicated above, H3K27me3 and H3K9me3 are often found
at promoter regions. In fact, initial studies of H3K27me3 and
H3K9me3 using ChIP-chip and promoter arrays identified large
sets of promoters that were distinguished by these two marks, often
in a cell type-specific pattern [9,10,11,12]. However, when studies
were expanded to ChIP-chip using genomic tiling arrays and then
to genome-wide ChIP-seq, it became clear that H3K27me3 and
H3K9me3 were not only found at promoter regions but that these
marks could also spread over larger genomic regions. For
H3K27me3, the spreading patterns are generally found over
HOX gene clusters [9]. Analysis of the H3K9me3 mark is more
complicated. H3K9me3 has been found to cover various repetitive
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regions, such as centromeres, transposons, and tandem repeats
[13,14,15]. In addition, we have previously shown that the 39
exons of many zinc finger genes (ZNFs) are covered by H3K9me3
[10]. The purpose of this current study is to further investigate the
set of ZNF 39 exons that are highly enriched for the H3K9me3
mark.
Results
The 39 ends of ZNF genes do not have characteristics of
promoter regions. As indicated above, H3K9me3 is often
associated with promoter regions but our previous studies showed
that it specifically covers the 39 exons of many ZNF genes. Because
H3K9me3 is not generally associated with the 39 ends of genes, we
reasoned that it was possible that the 39 ends of the ZNF genes
may harbor previously unidentified promoters. To investigate this
hypothesis, we first performed a bioinformatic analysis. Others
[16] have previously identified a set of motifs that are highly
enriched in human promoters. If the 39 ends of the ZNF genes are
previously unidentified promoters, then we would expect the
known promoter motifs to be enriched in these regions. We
extracted the target region for each ZNF 39 end on chr19 that was
identified using ChIP-seq of hES cells as being enriched for
H3K9me3 (121 genes). As a positive control set for human
promoters, we selected +/- 500 bp from the center of the
transcription start site of each ZNF target gene and as a negative
control set we selected ‘‘enhancer regions’’, which we define as
1000 nt regions located from 210,000 to 211,000 nt upstream of
the promoter of each ZNF gene bound by H3K9me3 at its 39 end
(note that if these enhancer regions overlapped any known
promoter regions, they were excluded from analysis). Each of the 3
sets of sequences (upstream negative controls, ZNF promoters, and
ZNF 39 ends) from the 121 ZNF genes were analyzed for the
occurrence of the position weight matrix (as defined in [16]) for the
promoter-enriched motifs CAAT, CREB, NRF2, GC, Inr, NRF1,
Sp1, and YY1 using the program MAST. Motifs with an E-value
below 10 were used for evaluation and each region was searched
for the motif in the forward and reverse orientation. Then, the
number of motifs per 1kb region was determined for each category
(upstream negative controls, ZNF promoters, and ZNF 39 ends) to
normalize the analysis (Figure 1A). As expected, most of the
promoter motifs are found in the ZNF promoters and some motifs
are found in the enhancer regions. However, the 39 ends of the
ZNF genes do not contain the known promoter motifs.
Of course, it is possible that promoters embedded in ZNF 39
exons might be regulated by a different set of transcription factors
and thus would not show enrichment of the common promoter
motifs. Therefore, we next investigated whether we could associate
the H3K9me3 binding sites with 59 ends of transcripts. For these
analyses, we obtained all CAGE tags available from the Riken
CAGE database (http://gerg01.gsc.riken.jp/cage/download/
hg17prmtr/chromosomes/). The number of CAGE tags were
counted for each region (upstream negative controls, ZNF
promoters, and ZNF 39 ends) and normalized for region size. As
shown in Figure 1B, the set of ZNF promoters could be associated
with the CAGE tags but very few CAGE tags could be found that
corresponded to the upstream enhancer regions or to the
H3K9me3 sites at the ZNF 39 ends. Thus, bioinformatic analyses
do not provide strong support for the hypothesis that ZNF 39
exons are promoter regions.
As a third approach to test the hypothesis that the 39 exons of
ZNF genes are promoters, we cloned a set of the 39 exons into a
luciferase reporter vector (Figure 2A). As positive controls for these
assays, we used the DHFR promoter (a well-studied housekeeping
promoter that is active in all cell types) and the promoter regions of
the ZNF554 and ZNF440 genes. Eight ZNF 39 ends were analyzed
for promoter activity. It was possible that the ZNF 39 ends could
be promoters oriented such that they produced antisense
transcripts relative to that same ZNF gene or they could be
alternative upstream promoters of a downstream gene. Therefore,
we cloned 5 of the ZNF 39 ends in both orientations upstream of
the luciferase cDNA so that we could analyze transcriptional
activity in both directions. To begin, HepG2 and DAOY cells
were transfected with the various reporter constructs and luciferase
activity was determined. As expected, the DHFR, ZNF554, and
ZNF440 promoters were active in both cell types. However, none
of the ZNF 39 ends showed any promoter activity in either
orientation (Figure 2B). We have shown previously that the ZNF
39 ends bound by H3me3K9 are also bound by KAP1 (also called
TRIM28) [10]. KAP1 is a corepressor that recruits the histone
methyltransferase SETDB1, resulting in trimethylation of histone
H3 on lysine 9 [10,17]. It is postulated that when KAP1 is located
at promoter regions, it can function to repress transcription by
recruiting a histone methyltransferase and other repressive
proteins such as HP1 family members [18]. Thus, it was possible
that potential promoter activity from the ZNF 39 exons was
suppressed due to KAP1-mediated repression. Therefore, we also
transfected the various promoter-luciferase constructs into both
U2OS cells and HEK293 cells that were stably expressing shRNAs
against KAP1 [18,19]. However, even under conditions of KAP1
knockdown, none of the tested 39 ends of the ZNF genes
functioned as a promoter in the luciferase reporter assays
(Figure 2C, 2D). Therefore, neither bioinformatics analyses nor
a functional assay provides support for the hypothesis that the 39
exons of the ZNF genes are cryptic promoters, even though they
are bound by a mark (H3K9me3) often found at promoter regions.
The 39 exons of ZNF genes have histone modifications
characteristic of both silenced and active regions. As indicated
above, H3K9me3 is generally considered to be a mark of
repression due to its colocalization with the KAP1 corepressor
and the HP1 family of silencing proteins. However, the unusual
location of the H3K9me3 marks at the 39 exons of ZNF genes may
suggest that this mark is functioning in a different manner for this
set of genes. To investigate whether the ZNF genes that are bound
by H3K9me3 are active or repressed, we analyzed the ZNF genes
for additional histone modifications, including ChIP-seq data for
H3K4me3, H3K4me1, H3AcK9, H3K27me3, and H3K36me3.
The only other mark that was found at the ZNF 39 ends was
H3K36me3, a mark of transcriptional elongation. As shown in
Figure 3, the ZNF 39 ends that have H3K9me3 also have high
levels of the H3K36me3 mark. Although the binding patterns of
H3K9me3 and H3K36me3 are similar over many ZNF genes,
there are clearly many regions identified by H3K9me3 but not by
H3K36me3 (e.g. 59680000 and 60060000 which includes a cluster
of killer cell and leukocyte immunoglobulin-like receptors). As
expected, there are also many regions identified by H3K36me3
and RNA-seq (e.g. the RPS9 gene at ,5940000) but not by
H3K9me3. To examine the relationship between H3K9me3 and
H3K36me3 on a genome-wide scale, we analyzed hES cell ChIP-
seq data obtained using the H3K9me3 and H3K36me3
antibodies. To do so, we first needed to modify Sole-search, our
ChIP-seq peak-calling program [20]. This program was originally
developed to analyze the binding patterns of site-specific DNA
binding proteins, which produce very narrow peaks in ChIP-seq
analyses. The binding patterns of modified histones, in particular
H3K9me3 and H3K36me3, are not narrow but instead can
spread over large regions and exhibit very jagged enrichment
profiles. Therefore, we modified the program such that it allows
Contradictory Chromatin Signatures on ZNF 39 Exons
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Figure 1. ZNF 39 ends are not enriched for promotermotifs or CAGE tags. (A) The 39 ends of the ZNFs bound by H3K9me3, as well as a 1kb region
centered on the start site (promoter) and a 1 kb region located 10 kb upstream (enhancer) of the same genes were searched in forward and reverse
orientations for the sequence of nine motifs previously found to be enriched in promoter regions [16]. Since the sizes of the H3K9me3 regions varied from
site to site, the data was normalized such that the motif counts are reported as the number of motifs found per 1000 base pairs. (B) The number of CAGE
tags corresponding to the regions of the 39 ends of the ZNFs bound by H3K9me3, as well as a 1 kb region centered on the start site (promoter) and a 1 kb
region located 10 kb upstream (enhancer) of the same genes was determined; the data was normalized as described in Figure 1A.
doi:10.1371/journal.pone.0017121.g001
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‘‘binding regions’’ rather than narrow peaks to be identified; see
Supplementary Information S1 and Figure S1 for more details
about Sole-searchv2. A comparison of the number of called peaks
and genomic coverage using the standard versus the histone
parameters is shown in Table 1; the most important difference is
that a larger region of the genome is identified as being covered by
histone marks using the modified program. Using the histone-
specific program parameters, we identified 20,744 H3K9me3
regions and 32,685 H3K36me3 regions. However, only 2,813
regions are covered by both types of modified histones (Figure 4A).
We further characterized the 2,813 regions marked by both
H3K9me3 and H3K36me3. First we determined how many
RNA-seq tags mapped to the H3K36-specific regions, the
H3K9me3-specific regions, and the regions covered by both
marks. As expected, the regions covered only by H3K36me3 were
transcribed and the regions covered only by H3K9me3 were not
transcribed (Figure 4B). Interestingly, the dual bound regions
display modest transcription levels, suggesting that the presence of
a H3K9me3 mark is not incompatible with transcription. Then,
we mapped the dual covered regions to the nearest gene and used
the DAVID gene ontology program [21] to identify specific
functional classes of genes showing these dual patterns. Strikingly,
the main gene category identified was Krueppel-associated C2H2
zinc finger genes (243 genes), with a minor category of cadherins
(25 genes) (Figure 4C). The cadherins are all clustered on
chromosome 5 and consist of a tandem array of alternatively
used 59 exons and common 39 exons. Unlike the 39 exon-specific
marking of the ZNFs by H3K9me3 and H3K36me3, it is the
promoter regions and alternatively used 59 exons of the cadherin
genes that are dually bound by the two histone marks.
The H3K9me3 mark is not repressive when located at ZNF 39
ends. Our ChIP-seq results suggested the possibility that the ZNF
genes may be imprinted, with one allele transcribed (and covered by
H3K36me3) and one allele repressed (and covered by H3K9me3).
To test the hypothesis that the contradictory modifications are due
to imprinting, we examined levels of RNA corresponding to the
ZNF genes in hES cells, using RNA-seq data [22]. We found that
the ZNF exons that show enrichment for H3K9me3 are transcribed
in hES cells (Figure 5A). To further investigate the role of
H3K9me3, we identified the top 716 H3K9me3 sites and separated
them based on whether they were located in a promoter region (183
sites) or within a gene (433 sites). As shown in Figure 5B, promoter
regions bound by H3K9me3 are associated with a very low number
of RNA-seq tags in hES cells whereas regions within genes that are
Figure 2. The 39 ends of ZNF genes do not display promoter
activity. A) ChIP-seq signal tracks from Ntera2 cells are shown for the
ZNF440 gene. H3K4me3 binding is observed at the promoter (top
panel), while H3K9me3 localizes to the 39 end of the ZNF440 gene
(bottom panel). The number of sequenced tags is plotted on the y-axis.
Shown below the ZNF440 gene schematic are representative constructs
for the experiments shown in panels B–D. Promoter regions (from
,500 bp upstream to ,100 bp downstream of TSS) and 39 regions
bound by H3K9me3 in vivo were cloned in front of the luciferase cDNA;
the 39 regions were cloned in either the sense (s) or antisense (as)
direction (see Table S2 for coordinates of the genomic fragments used
for promoter analyses). B–D) Luciferase assays were performed to test
for promoter activity at 39 ends of ZNF genes. The DHFR, ZNF440 and
ZNF554 promoters were used as positive controls and an empty vector
(EV) was used as a background control. Promoter activity was tested in
Ntera2 and DAOY cells B), in U2OS cells (C) and in HEK293 cells (D). In
addition, the U2OS and HEK23 cells were also stably transfected with a
KAP1 shRNA construct (indicated as KAP1 KD). Fold luciferase was
determined based on the empty vector control and is plotted on the y-
axis.
doi:10.1371/journal.pone.0017121.g002
Contradictory Chromatin Signatures on ZNF 39 Exons
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bound by H3K9me3 are associated with a larger number of RNA-
seq tags. Thus, both RNA analyses and chromatin modification
analyses suggest that ZNF genes having H3K9me3 on their 39 exons
are transcribed from at least one allele.
If only one allele of the ZNF genes is transcribed, one might
expect that the H3K9me3 and H3K36me3 peak heights at the
dually covered regions would be approximately half the peak
heights of the marks at the singly covered sites (because only one
allele would contribute to each signal in the dually covered sites
whereas both alleles would contribute to the signal in the singly
covered sites). However, the average height of the H3K9me3
peaks at 39 ZNF exons that had both marks was higher than the
average height of the H3K9me3 peaks at 39 ZNF exons that had
only H3K9me3. Similarly, the average height of the H3K36me3
peaks at 39 ZNF exons that had both marks was higher than the
average height of the H3K36me3 peaks at 39 ZNF exons that had
only H3K36me3 (data not shown). Although not conclusive, these
results suggested that the H3K9me3 and H3K36me3 marks on the
dually bound ZNF 39 exons may not be limited to only one allele.
We next used the program ssahaSNP to identify single nucleotide
polymorphisms (SNPs), as compared to the reference genome
sequence, that were located within genes targeted by both
H3K9me3 and H3K36me3 on chromosome 19. We then
searched for these SNPs within the RNA-seq dataset. Out of 72
SNPs that were identified, 40 SNPs and 3 wt nts were fixed in the
RNA sequence data (the SNP or wt nt composed .90% of all
nucleotides sequenced for this position). This could suggest either
that the ZNFs containing these SNPs were expressed in an allele-
specific manner or that the SNP was fixed in the ES cell genome.
However, we did identify 29 cases where both wt and SNP alleles
are present in the RNA-seq tags approximately equally (Table 2
and Table S3). Since both alleles are transcribed, the hypothesis
that transcription is allele-specific is not supported for these ZNF
genes bound by both H3K9me3 and H3K36me3.
Figure 3. ZNF39 ends are marked by H3K36me3. Shown for a region of chromosome 19 (hg18 coordinates) are the RNAseq, H3K36me3, and
H3K9me3 patterns for hES cells. Also shown is a track that indicates the position of the ZNF genes within that region. The hES RNAseq and ChIP-seq
experiments were performed as part of the NIH Roadmap Epigenome Mapping Consortium (http://www.roadmapepigenomics.org/). The RNAseq
data and the H3K4me3 and H3K9me3 modifications of a small set of loci have been previously analyzed as part of a previous publication [22].
doi:10.1371/journal.pone.0017121.g003
Table 1. Analysis of ChIP-seq data.
Original Sole-Search Modified Version
Peaks Total coverage (bp) Peaks Total coverage (bp) Fold difference
H3K4me3 9,868 3,416,942 10,165 14,139,035 4.1
H3K36me3 27,811 9,672,419 32,685 65,057,655 6.7
H3K9me3 26,728 9,212,672 20,744 35,215,276 3.8
Shown are the number of peaks called and the total number of bp covered by each peak set for H3K4me3, H3K36me3, and H3K9me3 using the original Sole-search
program or the program which has been modified to identify broad regions covered by modified histones. Also shown in the increase in genome coverage (fold
difference) that results when using the modified peak calling program. Both the original and the modified program can be accessed at http://chipseq.genomecenter.
ucdavis.edu/cgi-bin/chipseq.cgi.
doi:10.1371/journal.pone.0017121.t001
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H3K9me3 and H3K36me3 are not co-regulated. The studies
presented above suggest that the H3K9me3 and H3K36me3
marks on the dually bound ZNF39 exons are not mutually
exclusive. We next wished to investigate whether the dual
H3K9me3 and H3K36me3 marks are co-regulated. To investigate
this hypothesis, we used a method that we have previously
developed called eChIP, which allows the in vivo study of a
chromosomal region removed from its normal chromosomal
Figure 4. ZNFs are the largest category of genes that have both H3K9me3 and H3K36me3 marks. (A) Shown is a Venn diagram
indicating the number of regions bound by H3K9me3, H3K36me3, and both marks, as determined by analysis of hES cell ChIP-seq data using Sole-
searchv2. (B) The number of RNA-seq tags corresponding to regions identified as bound by H3K9me3 alone, H3K36me3 alone, and by both H3K9me3
and H3K36me3 is plotted. (C) The regions bound by both H3K36me3 and H3K9me3 were analyzed using the DAVID gene ontology program [21]. The
gene nearest to each binding site was chosen for analysis; shown are the enriched terms and P-value of enrichments.
doi:10.1371/journal.pone.0017121.g004
Contradictory Chromatin Signatures on ZNF 39 Exons
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location [23]. We cloned the 39 ends of ZNF555, ZNF556, and
ZNF77 into the episomal vector, introduced this vector into
HEK293 cells that express EBNA1 (required for the maintenance
of the episome), and then performed a ChIP analysis using
H3K9me3 and H3K36me3 antibodies. As a control, we first
demonstrated that in HEK293 cells the 39 ends of the endogenous
ZNF555, ZNF77, ZNF333, and ZNF426 genes are bound by both
H3K9me3 and H3K36me3 and that, as predicted from the hES
ChIP-seq results, the 39end of ZNF556 is bound only by
H3K9me3 and not by H3K36me3 (Figure 6A). We also showed
that the GAPDH gene is bound only by H3K36me3 and not by
H3K9me3, as expected for a highly transcribed gene and that the
GMNN promoter is not bound by either mark. We next analyzed
the episomal constructs. We observed high levels of H3K9me3 on
Figure 5. ZNF 39 exons are transcribed. (A) Shown for a region of chromosome 19 is the ChIP-seq pattern for H3K9me3 and the RNA pattern
obtained using RNAseq, both from hES cells. (B) Shown on the Y axis are the number of RNA-seq tags from hES cells corresponding to H3K9me3
bound regions that are classified as promoters (183 sites) or intragenic (433 sites).
doi:10.1371/journal.pone.0017121.g005
Contradictory Chromatin Signatures on ZNF 39 Exons
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the episomal ZNF 39 ends, but not on the GMNN promoter, an
episomal vector that does not contain an insert, or the hygromycin
cDNA region (Figure 6B). In contrast, analysis of the episomal
ZNF 39 ends showed that they are not marked by H3K36me3. As
a control to demonstrate that the H3K36me3 antibody could
detect the H3K36me3 mark on an episome, we analyzed the
hygromycin cDNA that is located on the same episomal vector as
the GMNN promoter and cloned downstream of a eukaryotic
promoter. Expression of hygromycin is used to select the stable
episomes and thus this cDNA is transcribed and we could detect
H3K36me3 in this region of the episome. These results
demonstrate that although both H3K9me3 and H3K36me3
marks show very high enrichment at the 39 ends of ZNFs, these
two marks are not co-regulated. H3K36me3 is produced by
SETD2 [24] and is thought to be recruited to the transcriptional
elongation complex via interaction with Ser 2-phosphorylated
RNA Polymerase II (reviewed in [25]); the levels of Ser 2-
phosphorylated RNA polymerase II, and thus also the levels of
H3K36me3, increase from the 59 to 39 direction throughout the
transcription unit. Our results show that the H3K9me3 deposition
is not dependent on the same mechanism as H3K36me3
deposition since the episomes have the H3K9me3 but not the
H3K36me3 mark. In fact, the high H3K9me3 mark on the
episomal ZNF 39 exons indicates that the cis elements required for
the mark are all present on the episomes. We have recently shown
that the KAP1/SETDB1 histone methylation complex colocalizes
with H3K9me3 [26]. Thus, the episomes must contain the cis
elements that can recruit the KAP1/SETDB1 complex.
H3K9me3 at ZNF 39 exons corresponds with the number of
tandemly repeated finger domains. ZNF genes contain multiple,
highly conserved finger domains in their 39 exons. In essence,
these finger domains create highly repetitive genomic regions.
H3K9me3 has been shown to bind to other repetitive elements,
such as transposons and centromeric repeats [13,14,15]. If the
H3K9me3 was binding to the ZFN 39 ends simply as a
consequence of the repetitive nature of these genomic regions,
then we would expect the likelihood of H3K9me3 to be bound to a
ZNF gene to increase as the number of finger domains increases.
To test this possibility, we classified the ZNF genes into sets
depending on how many tandomly repeated finger domains were
present in the gene and then plotted the percentage of each set
that is covered by H3K9me3 (Figure 7). We note that ZNFs that
have very few finger domains are rarely covered by H3K9me3,
whereas ZNFs having greater than 15 domains are almost always
covered by H3K9me3. Clearly, there is a strong relationship
between the number of tandemly repeated finger domains and the
likelihood of being covered by H3K9me3. In contrast, there is no
relationship between the number of repeated finger domains and
the likelihood of being covered by H3K36me3. As a further
analysis of the repetitive nature of H3K9me3 vs. H3K36me3
peaks, we examined 20,744 H3K9me3 peaks and 20,744
H3K36me3 peaks and searched for tandem repeats using the
program XSTREAM, identifying sequences that are 50bp or
larger, repeated at least 5 times in the human genome, and having
at least 60% conservation between repeat elements. We then
calculated the percentage of each peak that was a repetitive
element. We found that more of the H3K9me3 peaks consisted of
a high percentage of repetitive regions. For example, there are
,17 times more H3K9me3 peaks that consist of 91-100%
repetitive elements (see Figure S2).
Discussion
The focus of this study was to characterize the contradictory
chromatin marks found at the 39 ends of hundreds of ZNF genes in
the human genome. Because H3K9me3 has been shown to be
promoter-localized [9,27,28], we first investigated the possibility
Table 2. Analysis of RNA-seq SNPs.
Count
WT fixed 3
SNP fixed 40
Heterogeneous 29
Total 72
The program ssahaSNP was used to identify single nucleotide polymorphisms
(SNPs), as compared to the reference genome sequence, that were located
within genes targeted by both H3K9me3 and H3K36me3 on chromosome 19.
Out of 72 SNPs that were identified, 40 SNPs and 3 wt nts were fixed in the RNA
sequence data (the SNP or wt nt composed .90% of all nucleotides sequenced
for this position) but there were 29 cases where both wt and SNP alleles are
present in the RNA-seq tags approximately equally.
doi:10.1371/journal.pone.0017121.t002
Figure 6. H3K9me3 and H3K36me3 are not co-regulated at ZNF
39 ends. (A) ChIP experiments were performed in HEK293 cells using
antibodies specific for H3me3K9 and H3me3K36; IgG was used as a
negative control. Using primers specific for the endogenous chromo-
somal regions, the 39 exons of 4 ZNFs shown by ChIP-seq of hES cells to
be bound by both H3K36me3 and K3K9me3 (ZNF555, ZNF77, ZNF333,
and ZNF426) were show to be bound by both marks in the HEK293 cells.
In contrast, ZNF556, which bound only by H3K9me3 (as was predicted
from the ChIP-seq binding patterns from hES cells. The GAPDH gene
was used as a positive control for H3K36me3 and a negative control for
H3K9me3 and the GMNN promoter served as a negative control for
both marks. (B) eChIP experiments were performed (using primers
specific for the regions cloned into the episomal vectors) in HEK293
cells harboring episomal constructs containing the indicated regions.
Antibodies specific for H3me3K9 and H3me3K36 were used and IgG
was used as a negative control. Episomal constructs harboring the 39
ends of ZNF555, ZNF556, and ZNF77 were analyzed; an empty episomal
vector and an episomal vector harboring the GMNN promoter were
used as negative controls. The hygromycin cDNA (located on the
opposite side of the episome from the cloning site) was used as a
positive control for H3K36me3.
doi:10.1371/journal.pone.0017121.g006
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that the 39 ends of ZNF genes harbor cryptic or previously
uncharacterized promoters. However, neither bioinformatic nor
experimental approaches support the hypothesis that the 39 exons
of ZNFs are promoter regions. We next analyzed genome-wide
ChIP-seq data for H3K9me3 and H3K36me3 and found that
although there are ,18,000 H3K9me3 and ,30,000 H3K36me3
regions in human ES cells, these two modified histones are found
together at very few genomic locations. The reason for the low
overlap is that H3K36me3 is a mark of transcriptional elongation
(and thus covers intragenic regions downstream of promoters)
whereas H3K9me3 is mainly found at promoter regions or in large
transcriptionally inactive domains. In fact, ZNF 39 exons
constitute the vast majority of the overlapping H3K9me3 and
H3K36me3 sites in the human genome. Although the patterns of
H3K9me3 and H3K36me3 are very similar on ZNF genes, we
have used episomal ChIP assays to show that the marks are not co-
regulated.
It is thought that the H3K9me3 histone modification serves as a
transcriptionally repressive mark. However, others have shown
that H3K9me3 can be found to co-localize with RNAPII or
H3K9Ac on promoters [9,27] and is also present on some
transcribed regions [28,29]. Therefore, simply identifying a region
as being marked by H3K9me3 does not provide information as to
whether the gene is transcribed. There are other examples of
contradictory marks being located on certain genes. For example,
imprinted genes have both H3K9me3 and H3K4me3 marks, with
the repressive H3K9me3 being located on one parental allele and
the active H3K4me3 mark being enriched on the other parental
allele [30]. For these cases, the contradictory marks are located at
the promoter regions and only one allele is transcribed. Another
set of contradictory chromatin marks includes the bivalent
promoters that have both H3K4me3 and H3K27me3 [31]. In
this case, the repressive H3K27me3 mark is dominant and the
genes are not transcribed. Our analyses show that the ZNF genes
that have both H3K9me3 and H3K36me3 are transcribed (unlike
the bivalent marks) and, for at least some ZNFs, the transcripts are
not allele-specific (unlike the imprinted genes). We also note that
the nucleosomes at the 39 ends of the ZNF genes that have the
H3K9me3 and H3K36me3 marks do not have either H3K4me3
or H3K27me3 (Figure 2 and data not shown). Another distinction
between the dual H3K9me3 and H3K36me3 marks found on
ZNF genes and the bivalent H3K4me3 and H3K27me3 marks
found on HOX genes is that the H3K4me3 and H3K27me3
bivalent marks are found only on chromatin from embryonic cells
whereas the dual H3K9me3 and H3K36me3 marks at 39 ZNF
exons are found in every cell type that we have examined,
including both embryonic and adult cells as well as normal and
cancer cells (Figure 8).
Because the ZNF genes covered by H3K9me3 at their 39 exons
are transcribed, we suggest that H3K9me3 may not be involved in
repressing transcription of these genes. Rather, H3K9me3 may
serve to create a more condensed chromatin structure that can
inhibit inappropriate homologous recombination between differ-
ent highly related ZNF genes. We have shown that there is a
strong relationship between the number of tandemly repeated
finger domains and the likelihood of being covered by H3K9me3
(but not by H3K36me3, which correlates with the transcript level
and not the number of fingers in a particular ZNF gene). Also, we
have found that when ZNF genes are introduced into cultured
human cells, they very often become truncated at their 39 ends
(Iyengar and Farnham, unpublished data). It is possible that the
‘‘unprotected’’ plasmid DNA corresponding to the ZNF 39 exons
Figure 7. H3K9me3 enrichment at ZNF 39 ends correlates with the number of finger domains. Shown is the percentage of ZNF genes
having the specified numbers of zinc fingers that are targeted by H3K9me3 or H3K36me3 (ZNF genes having from 1 to 25 zinc fingers were used for
this analysis).
doi:10.1371/journal.pone.0017121.g007
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serves as a recombination template, resulting in recombination
and mutation of the introduced gene. Future studies are required
to address the possible role of H3K9me3 (and the enzyme
complexes that mediate this histone modification) in suppression of
homologous recombination amongst the hundreds of ZNF genes.
Finally, we note that to accurately compare genomic regions
enriched for spreading histone modifications such as H3K9me3
and H3K36me3, we developed a modified peak calling program
that takes into account duplicated regions of the genome, biases in
sequencing of certain regions, and the jagged profile of regions
enriched for histone modifications. This program, Sole-searchv2,
is publicly available at http://chipseq.genomecenter.ucdavis.edu/
cgi-bin/chipseq.cgi.
Methods
Luciferase assays: Luciferase assay constructs were created by
ligating PCR products into pGL4-11 (Promega) upstream of the
luciferase gene. The pGL4-11b-DHFR control plasmid was
provided by SwitchGear Genomics. Plasmids containing ZNF440
or ZNF544 gene promoters and 39 regions of ZNF genes were
cloned using XhoI/HindIII restriction sites. All other ZNF
constructs were created by blunt cloning into SmaI restriction
site. For luciferase assays, HepG2 (ATCC #HB-8065), DAOY
(ATCC #HTB-186), U2OS(ATCC #HTB-96), and HEK293
(ATCC #CRL-1573) cells were grown in DMEM supplemented
with 10%FBS, 2 mM L-Glutamine, 100 U/mL Penicillin/Strep-
tomycin. Stable KAP1 knockdown cell lines K928-cI10 (HEK293)
and U2OS-K4 (U2OS) were kindly provided by David Schultz
[18,19]. K928-cl10 cells were grown as above with the addition of
10 mg/ml puromycin, U2OS-K4 cells were grown in the presence
of 200 mg/ml zeocin. Cells were plated in 24 well dishes at a
density of 30,000 cells per well. The following day, cells were co-
transfected with 100 ng luciferase plasmid and 5 ng Renilla
reporter plasmid phRL-SV40 (Promega) using Effectene (QIA-
GEN) according to the manufacturer’s instructions. Cells were
lysed 48 hours post transfection and luciferase activity was
determined using the Dual-Luciferase Reporter Assay System
(Promega) according to the manufacturer9s protocol. Luciferase
values were normalized using Renilla values.
ChIP-seq. ChIP-seq was performed as described in Supple-
mentary Information S1. Briefly, cells were crosslinked, chromatin
was extracted and sonicated to an average size of 300–500 bp, and
individual ChIP assays were performed using antibodies to
modified histones and protein G-coupled magnetic beads. ChIP
libraries were created as described previously [32], using 15–18
cycles of amplification. Libraries were run on a 2% agarose for gel
purification. Library DNA was quantitated using either a
Nanodrop or a BioAnalyzer and sequenced on an Illumina GA2
by the DNA Technologies Core Facility at the University of
California-Davis (http://genomecenter.ucdavis.edu/dna_technol
ogies/) or at the University of British Columbia Genome Science
Center. Lists of all the ChIP-seq experiments and information
concerning the antibodies used for each histone mark are provided
in Table S1 and the coordinates of the primers used for ChIP
assays are listed in Table S2; see Supplementary Information S1
for antibody validation. The hES ChIP-seq experiments were
performed as part of the NIH Roadmap Epigenome Mapping
Consortium (http://www.roadmapepigenomics.org/) and a small
set of loci have been previously analyzed using these datasets [22].
ChIP-seq peakcalling. Peaks were identified using version 2 of
the Sole-search software. Version 2 of this program has been
designed to run more quickly and efficiently on the increasingly
large ChIP-seq data sets, to more accurately analyze ChIP-seq
data from any species, and to improve peak-calling for proteins
and histone modifications which are characterized by spreading.
Figure 8. ZNF 39 exons are covered by H3K9me3 and H3K36me3 in both pluripotent and differentiated cell types. Shown are the
ChIP-seq profiles of H3K9me3 and H3K36me3 for a section of chromosome 19 from Ntera2 (pluripotent testicular embryonal carcinoma from a 22
year old male), Proliferating Blood Mononuclear Cells (PBMC) from a 28 year old male), K562 (chronic myelogenous leukemia from a 53-year-old
female), and U2OS (moderately differentiated sarcoma of the tibia of a 15 year old girl) cells. The number of sequenced tags is plotted on the y-axis,
the positions of 3 ZNF genes are indicated on the x axis (the direction of transcription is indicated by the arrows), and the antibody used for each
experiment is indicated on the right side of the figure.
doi:10.1371/journal.pone.0017121.g008
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Several changes, as compared to the original Sole-search program
[20], were implemented to achieve these goals. This new software
is comparable to its predecessor in the ability to accurately
determine transcription factor binding sites but greatly improves
peak-calling for spreading marks, such as histone modifications;
see Supplementary Information S1 and Figure S1 for more details.
Episomal ChIPs (eChIPs): All regions to be cloned into the
episomal vector (with the exception of GMNN which has been
described previously in [23] were amplified from Ntera2 genomic
DNA by PCR with Pfx Polymerase (Invitrogen) using primers that
introduced unique XhoI and HindIII sites immediately 59 and 39
to the region of interest, respectively. The target sequences were
then cloned into the pFC62 episome using the XhoI and HindIII
sites; successful cloning of the various inserts was confirmed by
sequencing at the UC Davis Sequencing Facility. The episomal
constructs (1 mg) were transfected into HEK293c18 cells stably
expressing EBNA-1 in 6-well dishes using FuGene 6 Transfection
Reagent (Roche) according to manufacturer’s recommendations.
Forty-eight hours after transfection, cells were selected in medium
containing 500 mg/ml of G418 (Sigma) and 200 ug/ml Hygro-
mycin B (CellGro), and drug resistant colonies were pooled and
expanded. Pooled colonies were assayed for the presence of the
correctly sized episomal insert using primers that flanked the
cloning site and genomic DNA prepared from the stably
transfected cells. To perform the eChIP assays, HEK293cl18 cells
stably transfected with a particular episome were harvested when
the cells were ,75% confluent. Cells were cross-linked and
chromatin was prepared and analyzed using our standard ChIP
protocol (http://www.genomecenter.ucdavis.edu/farnham) with a
few modifications. Namely, ,20 ug of chromatin was used for
each IP and the amount of antibody was greatly reduced (0.2 ug of
Anti-H3me3K9 (Abcam, #8898), Anti-H3me3K36 (Diagenode,
# pAb-058-050), or non-specific rabbit IgG antibody (Alpha
Diagnostics, # 20009-5) was used). Complexes were recovered
with 10 uls of StaphA cells for 15 minutes at room temperature.
Washes, elution and purification of the ChIP samples were
performed according to the standard protocol. PCR reactions
were performed using only 1 ul of the immunoprecipitated sample
and amplified for only 28 cycles.
Supporting Information
Supplementary Information S1 This file includes a descrip-
tion of Sole-search version 2, antibody validation documents, and
the ChIP-seq protocol.
(PDF)
Figure S1 Major steps implemented in Sole-searchv2.
The original Sole-search program has been modified to improve
the ability to determine statistically and biologically significant
peaks in both transcription factor and histone modification
datasets. (A) Input data is smoothed and duplication and deletion
events are determined based on fold coverage of these regions
compared to average coverage. Next, specific regions of the
genome that have a higher sequence coverage than expected by
chance, due to experimental method, are determined using a t-
statistic. Raw ChIP-seq data is normalized based on duplication
event copy number and enrichment of input reads, so that the data
to be analyzed will reflect a single copy genome without
sequencing bias (see the track corresponding to ‘‘Normalized
ChIP-seq data’’). (B) The second, optional step smoothes data that
spreads over large regions (e.g. data from histone modification
ChIP-seq experiments), using a sliding average, so that non-
uniform ‘‘mountain range’’ peaks are more easily detectable as
broad regions. Previously, these regions would be identified as
having many, distinct peaks. Also certain smaller peaks would fail
to be detected. This smoothing step allows detection of both broad
regions and smaller. (C) The third major step determines a
statistically significant peak height cutoff. Tags are randomly
sampled from the input dataset to create bins. Tags are then
shuffled within the bins. Height cutoff is determined based on a
user-defined FDR. The cutoff value increases until the number of
peaks found within the randomly generated background is
sufficiently low, compared to the number of peaks found in the
ChIP-seq dataset at the same height.
(PDF)
Figure S2 20744 H3K9me3 peaks and 20744 H3K36me3
peaks were searched for tandem repeats using the
program XSTREAM (http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC2233649/), identifying sequences
that are 50bp or larger, repeated at least 5 times in
the human genome, with at least 60% conservation
between repeat elements. The percent of each peak that was a
repetitive element was then calculated. A greater number of the
H3K9me3 peaks had high percentages of repetitive regions. For
example, there are ,17 times more H3K9me3 peaks that consist
of 91-100% repetitive elements.
(PDF)
Table S1 Summary table of ChIP-seq data sets.
(PDF)
Table S2 List of primers used in this study.
(PDF)
Table S3 RNA-seq SNP frequencies.
(XLSX)
Acknowledgments
We thank Drs. Ivanov, Schultz, and Rauscher for providing the KAP1
knockdown cells.
Author Contributions
Conceived and designed the experiments: KRB HO PJF. Performed the
experiments: KRB LE SI HO ES YZ. Analyzed the data: KRB HO PJF.
Contributed reagents/materials/analysis tools: LD JFC. Wrote the paper:
KRB PJF. Was involved in creating the ChIPseq sequencing pipeline:
MAM MH. Advised in software design: IK.
References
1. Crews D (2010) Epigenetics, brain, behavior, and the environment. Hormones
(Athens) 9: 41–50.
2. Grayson DR, Chen Y, Dong E, Kundakovic M, Guidotti A (2009) From trans-
methylation to cytosine methylation: evolution of the methylation hypothesis of
schizophrenia. Epigenetics 4: 144–149.
3. Iwamoto K, Kato T (2009) Epigenetic profiling in schizophrenia and major
mental disorders. Neuropsychobiology 60: 5–11.
4. Jiang Y, Langley B, Lubin FD, Renthal W, Wood MA, et al. (2008) Epigenetics
in the nervous system. J Neurosci 28: 11753–11759.
5. McCarthy MM, Auger AP, Bale TL, De Vries GJ, Dunn GA, et al. (2009) The
epigenetics of sex differences in the brain. J Neurosci 29: 12815–12823.
6. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128: 683–692.
7. Ellis L, Atadja PW, Johnstone RW (2009) Epigenetics in cancer: targeting
chromatin modifications. Mol Cancer Ther 8: 1409–1420.
Contradictory Chromatin Signatures on ZNF 39 Exons
PLoS ONE | www.plosone.org 11 February 2011 | Volume 6 | Issue 2 | e17121
8. Lund AH, van Lohuizen M (2004) Epigenetics and cancer. Genes Dev 18:
2315–2335.
9. Squazzo SL, Komashko VM, O’Geen H, Krig S, Jin VX, et al. (2006) Suz12
silences large regions of the genome in a cell type-specific manner. Genome
Research 16: 890–900.
10. O’Geen H, Squazzo SL, Iyengar S, Blahnik K, Rinn JL, et al. (2007) Genome-
Wide Analysis of KAP1 Binding Suggests Autoregulation of KRAB-ZNFs. PLoS
Genet 3: e89.
11. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, et al. (2006) Control
of developmental regulators by Polycomb in human embryonic stem cells. Cell
125: 301–313.
12. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K (2006) Genome-wide
mapping of Polycomb target genes unravels their roles in cell fate transitions.
Genes Dev 20: 1123–1136.
13. Verdel A, Moazed D (2005) RNAi-directed assembly of heterochromatin in
fission yeast. FEBS Lett 579: 5872–5878.
14. Zaratiegui M, Irvine DV, Martienssen RA (2007) Noncoding RNAs and gene
silencing. Cell 128: 763–776.
15. Martens JH, O’Sullivan RJ, Braunschweig U, Opravil S, Radolf M, et al. (2005)
The profile of repeat-associated histone lysine methylation states in the mouse
epigenome. Embo J 24: 800–812.
16. Lin JM, Collins PJ, Trinklein ND, Fu Y, Xi H, et al. (2007) Transcription factor
binding and modified histones in human bidirectional promoters. Genome Res
17: 818–827.
17. Frietze S, O’Geen H, Blahnik KR, Jin VX, Farnham PJ (2010) ZNF274 recruits
the histone methyltransferase SETDB1 to the human genome. Dec 8; 5(12):
e15082.PMID: 21170338.
18. Sripathy SP, Stevens J, Schultz DC (2006) The KAP1 corepressor functions to
coordinate the assembly of de novo HP1-demarcated microenvironments of
heterochromatin required for KRAB zinc finger protein-mediated transcrip-
tional repression. Mol Cell Biol 26: 8623–8638.
19. Ivanov AV, Peng H, Yurchenko V, Yap KL, Negorev DG, et al. (2007) PHD
domain-mediated E3 ligase activity directs intramolecular sumoylation of an
adjacent bromodomain required for gene silencing. Mol Cell 28: 823–837.
20. Blahnik KR, Dou L, O’Geen H, McPhillips T, Xu X, et al. (2010) Sole-search:
An integrated analysis program for peak detection and functional annotation
using ChIP-seq data. Nucleic Acids Res 38: e13.
21. Dennis GJ, Sherman BT, Hosack Da, Yang J, Gao W, et al. (2003) DAVID:
Database for annotation, visualization, and integrated discovery. Genome Biol 4:
P3.
22. Harris RA, Wang T, Coarfa C, Zhou X, Xi Y, et al. (2010) Sequence-based
profling of DNA methylation: comparisons of methods and catalogue of allelic
epigenetic modifications. Nature Biotechnology In Press.
23. Rabinovich A, Jin VX, Rabinovich R, Xu X, Farnham PJ (2008) E2F in vivo
binding specificity: comparison of consensus vs. non-consensus binding sites.
Genome Research 18: 1763–1777.
24. Edmunds JW, Mahadevan LC, Clayton AL (2008) Dynamic histone H3
methylation during gene induction: HYPB/Setd2 mediates all H3K36
trimethylation. EMBO J 27: 406–420.
25. Hampsey M, Reinberg D (2003) Tails of intrigue: phosphorylation of RNA
polymerase II mediates histone methylation. Cell 113: 429–432.
26. Frietze S, O’Geen H, Blahnik KR, Jin VX, Farnham PJ () ZNF274 recruits the
histone methyltransferase SETDB1 to the human genome. In Press.
27. Wiencke JK, Zheng S, Morrison Z, Yeh R-F (2007) Differentially expressed
genes are marked by histone 3 lysine 9 trimethylation in human cancer cells.
Oncogene advance online publication 29 October 2007.
28. Vakoc CR, Mandat SA, Olenchock BA, Blobel GA (2005) Histone H3 lysine 9
methylation and HP1gamma are associated with transcription elongation
through mammalian chromatin. Mol Cell 19: 381–391.
29. Miao F, Natarajan R (2005) Mapping global histone methylation patterns in the
coding regions of human genes. Mol Cell Biol 25: 4650–4661.
30. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, et al. (2007) Genome-
wide maps of chromatin state in pluripotent and lineage-committed cells. Nature
448: 553–560.
31. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, et al. (2006) A
bivalent chromatin structure marks key developmental genes in embryonic stem
cells. Cell 125: 315–326.
32. Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, et al. (2007) Genome-
wide profiles of STAT1 DNA association using chromatin immunoprecipitation
and massively parallel sequencing. Nat Methods 4: 1–7.
Contradictory Chromatin Signatures on ZNF 39 Exons
PLoS ONE | www.plosone.org 12 February 2011 | Volume 6 | Issue 2 | e17121
